Literature DB >> 17280669

Alternatives to mifepristone for early medical abortion.

N L Moreno-Ruiz1, L Borgatta, S Yanow, N Kapp, E R Wiebe, B Winikoff.   

Abstract

OBJECTIVE: To review published reports of first-trimester medical abortion regimens that do not include mifepristone.
METHODS: Reports listed in Pubmed and Medline on prospective and controlled trials of the efficacy of misoprostol, alone or associated with methotrexate, for first-trimester abortion were analyzed if they included more than 100 participants and were published since 1990.
RESULTS: The efficacy of regimens using misoprostol alone ranged from 84% to 96%, and when misoprostol was used with methotrexate the efficacy ranged from 70% to 97%. Efficacy rates were influenced by follow-up interval. Treatment for infection, bleeding, and incomplete abortion were infrequent with both methods (0.3%-5%).
CONCLUSION: Alone or in combination with methotrexate, misoprostol is an efficacious alternative to mifepristone for the medical termination of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280669     DOI: 10.1016/j.ijgo.2006.09.009

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  5 in total

1.  Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review.

Authors:  Elizabeth G Raymond; Margo S Harrison; Mark A Weaver
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

2.  Mentha pulegium L. (Pennyroyal, Lamiaceae) Extracts Impose Abortion or Fetal-Mediated Toxicity in Pregnant Rats; Evidenced by the Modulation of Pregnancy Hormones, MiR-520, MiR-146a, TIMP-1 and MMP-9 Protein Expressions, Inflammatory State, Certain Related Signaling Pathways, and Metabolite Profiling via UPLC-ESI-TOF-MS.

Authors:  Amira A El-Gazar; Ayat M Emad; Ghada M Ragab; Dalia M Rasheed
Journal:  Toxins (Basel)       Date:  2022-05-16       Impact factor: 5.075

3.  Uses of misoprostol in obstetrics and gynecology.

Authors:  Rebecca Allen; Barbara M O'Brien
Journal:  Rev Obstet Gynecol       Date:  2009

4.  Implementation of misoprostol for postabortion care in Kenya and Uganda: a qualitative evaluation.

Authors:  Joachim Osur; Traci L Baird; Brooke A Levandowski; Emily Jackson; Daniel Murokora
Journal:  Glob Health Action       Date:  2013-04-24       Impact factor: 2.640

5.  Women's self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria.

Authors:  Melissa Stillman; Onikepe Owolabi; Adesegun O Fatusi; Akanni I Akinyemi; Amanda L Berry; Temitope P Erinfolami; Olalekan S Olagunju; Heini Väisänen; Akinrinola Bankole
Journal:  BMJ Open       Date:  2020-05-05       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.